home / stock / anip / anip quote
Last: | $60.82 |
---|---|
Change Percent: | 0.0% |
Open: | $62.38 |
Close: | $60.82 |
High: | $62.41 |
Low: | $60.64 |
Volume: | 81,887 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$60.82 | $62.38 | $60.82 | $62.41 | $60.64 | 81,887 | 07-04-2024 |
$60.82 | $62.38 | $60.82 | $62.41 | $60.64 | 81,887 | 07-03-2024 |
$62.64 | $63.03 | $62.64 | $63.6 | $62.41 | 104,907 | 07-02-2024 |
$63.44 | $63.5 | $63.44 | $64.16 | $62.8 | 150,901 | 07-01-2024 |
$63.68 | $63.51 | $63.68 | $64.69 | $62.86 | 675,471 | 06-28-2024 |
$63.09 | $65.73 | $63.09 | $65.9 | $62.6 | 158,882 | 06-27-2024 |
$65.49 | $65.29 | $65.49 | $65.79 | $63.24 | 224,006 | 06-26-2024 |
$64.19 | $62.83 | $64.19 | $64.95 | $62.83 | 235,626 | 06-25-2024 |
$62.82 | $58.94 | $62.82 | $62.95 | $58.7594 | 236,464 | 06-24-2024 |
$58.53 | $59.48 | $58.53 | $59.865 | $58.43 | 325,423 | 06-21-2024 |
$59.39 | $60.19 | $59.39 | $60.73 | $59.3 | 169,017 | 06-20-2024 |
$60.74 | $61.82 | $60.74 | $62.355 | $60.326 | 156,853 | 06-19-2024 |
$60.74 | $61.82 | $60.74 | $62.355 | $60.326 | 156,853 | 06-18-2024 |
$61.78 | $62.55 | $61.78 | $62.67 | $60.69 | 108,943 | 06-17-2024 |
$62.62 | $62.73 | $62.62 | $63.12 | $62.05 | 91,792 | 06-14-2024 |
$63.24 | $63.8 | $63.24 | $64.58 | $62.57 | 135,728 | 06-13-2024 |
$64.21 | $65.74 | $64.21 | $66.51 | $63.43 | 133,779 | 06-12-2024 |
$64.93 | $64.6 | $64.93 | $65.17 | $63.49 | 143,506 | 06-11-2024 |
$64.98 | $65.68 | $64.98 | $65.795 | $64.18 | 196,637 | 06-10-2024 |
$66.74 | $68.56 | $66.74 | $68.68 | $66.52 | 303,940 | 06-07-2024 |
News, Short Squeeze, Breakout and More Instantly...
ANI Pharmaceuticals Inc. Company Name:
ANIP Stock Symbol:
NASDAQ Market:
ANI Pharmaceuticals Inc. Website:
PRINCETON, N.J., July 02, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that it received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) and launched Naproxen Delayed-Release Tablets, USP....
PRINCETON, N.J., June 25, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that its Chief Executive Officer, Nikhil Lalwani, has been named an Ernst & Young LLP (EY US) Entrepreneur Of The Year ® 2024 New Jersey Award winner. Entr...
2024-06-24 08:08:29 ET Alimera Sciences Inc (NASDAQ: ALIM) rallied a whopping 75% in premarket today after ANI Pharmaceuticals Inc (NASDAQ: ANIP) said it will buy the Alpharetta, Georgia based company for about $381 million. ANI shares are roughly flat at writing. Alimera Sc...